RENALYTIX PLC - AMERICAN DEPOSITARY SHARES

Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors

03 Jul 2023 06:00:00 By Nasdaq GlobeNewswire

FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney Disease

29 Jun 2023 17:01:17 By Nasdaq GlobeNewswire

KidneyIntelX™ Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific Conferences

15 Jun 2023 06:00:01 By Nasdaq GlobeNewswire

Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023

09 Jun 2023 06:00:54 By Nasdaq GlobeNewswire

Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9

05 Jun 2023 06:00:10 By Nasdaq GlobeNewswire

Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes

25 May 2023 06:00:00 By Nasdaq GlobeNewswire

New Published Real-World Evidence Shows KidneyIntelX™ Utility

19 Apr 2023 06:00:28 By Nasdaq GlobeNewswire

Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting

12 Apr 2023 06:00:26 By Nasdaq GlobeNewswire

Renalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Results

30 Mar 2023 06:00:16 By Nasdaq GlobeNewswire

Renalytix to Report Second Quarter and First Half Fiscal Year 2023 Financial Results on March 30

22 Mar 2023 06:00:27 By Nasdaq GlobeNewswire

Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

09 Feb 2023 06:00:12 By Nasdaq GlobeNewswire

Renalytix announces a c.$20.3 million private placement

08 Feb 2023 06:00:49 By Nasdaq GlobeNewswire

Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States

26 Jan 2023 06:00:01 By Nasdaq GlobeNewswire

Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems

09 Jan 2023 06:00:02 By Nasdaq GlobeNewswire

Primary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and Outcomes

01 Dec 2022 06:00:00 By Nasdaq GlobeNewswire

Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023

30 Nov 2022 06:00:01 By Nasdaq GlobeNewswire

Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease

29 Nov 2022 06:00:01 By Nasdaq GlobeNewswire

Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30

22 Nov 2022 06:00:00 By Nasdaq GlobeNewswire

Renalytix to Present at Stifel Healthcare Conference

03 Nov 2022 06:00:02 By Nasdaq GlobeNewswire

Renalytix Reports Full Year Fiscal 2022 Results

31 Oct 2022 06:00:01 By Nasdaq GlobeNewswire